Saw someone on another board mention IH and I have been hanging around a little while...I am "all-in" on Leronlimab. I saw it trending one day on most active stocks last year and did a few short term buys and sells. Once I started to actually look into the science of it, I put in the time and learned way more about "monoclonal antibodies", "CCR-5 receptors", and "cytokine storms" than I really wanted or intended to do. I bought 5,000 shares, it dipped, I bought another 5,000 shares and it dipped again.